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ABSTRACT
Objective To synthesise the views of patients and carers
indecisionmakingregardingtreatmentforchronickidney
disease, and to determine which factors influence those
decisions.
Design Systematic review of qualitative studies of
decision making and choice for dialysis, transplantation,
or palliative care, and thematic synthesis of qualitative
studies.
Data sources Medline, PsycINFO, CINAHL, Embase, social
work abstracts, and digital theses (database inception to
week 3 October 2008) to identify literature using
qualitative methods (focus groups, interviews, or case
studies).
Review methods Thematic synthesis involved line by line
coding of the findings of the primary studies and
development of descriptive and analytical themes.
Results 18 studies that reported the experiences of 375
patientsand87carerswere included.14studiesfocused
on preferences for dialysis modality, three on
transplantation, and one on palliative management. Four
major themes were identified as being central to
treatment choices: confronting mortality (choosing life or
death, being a burden, living in limbo), lack of choice
(medical decision, lack of information, constraints on
resources),gainingknowledgeofoptions(peerinfluence,
timing of information), and weighing alternatives
(maintaining lifestyle, family influences, maintaining the
status quo).
Conclusions The experiences of other patients greatly
influenced the decision making of patients and carers.
The problematic timing of information about treatment
options and synchronous creation of vascular access
seemed to predetermine haemodialysis and inhibit
choice of other treatments, including palliative care. A
preference to maintain the status quo may explain why
patients often remain on their initial therapy.
INTRODUCTION
Clinical guidelines in the United States, Canada, Uni-
ted Kingdom, Europe, and Australasia recommend
that treatment options for chronic kidney disease
include the preference of a fully informed patient.
1-3
In the UK alone, 7000 patients a year progress to end
stage kidney disease requiring transplantation, dialy-
sis, or “supportive non-dialytic” (palliative) care.
4 For
most of these patients progression to end stage kidney
disease can be anticipated, enabling patients’ prefer-
ences for treatment to be incorporated into their care.
Recent data from observational studies and the US
Renal Data System, however, suggest that patients
with chronic kidney disease may not be presented
with adequate information on treatment options or
given sufficient time in which to discuss management
alternativeswiththeirfamiliesorcarers.
5-8Lowratesof
kidney transplantation in patients on low incomes and
those from minority ethnic groups also suggest that
patientandfamilypreferencesarenotbeingtakeninto
account.
9-11
Although large numbers of patients with chronic
kidney disease exist worldwide, data on the factors
that influence preferences for treatment from a patient
or carer perspective are limited. Qualitative research
methodsusedinfocusgroupsorin-depthinterviewing
have the advantage of reporting the attitudes, feelings,
and beliefs of patients, allowing readers some insight
intotheirperspective.Asynthesisoffindingsfromsev-
eral qualitative studies in chronic kidney disease has
the ability to achieve a greater conceptual understand-
ingofthetopicbeyondasingleempiricalstudy.
12The-
matic synthesis, as first described in 1988,
13 draws on
the findings of original studies and uses those findings
as data in a subsequent analysis. This allows readers to
appreciate what has been discovered, build on what is
already known, and translate these findings into their
own clinical practice.
121415
Awareness of the factors associated with decision
making in the treatment of chronic kidney disease
can provide health professionals with evidence on
howbesttodelivereducationprogrammesforpatients
andtheirfamilies;itmayalsoenhancecommunication
and improve the capacity for patient and family invol-
vement in shared decision making. We synthesised
and analysed the views of patients and their informal
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kidney disease and determined which factors influ-
enced decisions about treatment.
METHODS
Thematic synthesis aims to achieve analytical abstrac-
tion at a higher level, by rigorously examining overlap
and elements in common among studies. We used
thematic synthesis to focus on patientand carer prefer-
ences, decision making, and choice for treatments in
patients with chronic kidney disease. This methodol-
ogy was chosen for two reasons. Firstly, it enabled the
analysis of a substantive literature in decision making
for all types of treatment for chronic kidney disease, as
no single study provided perspectives on transplanta-
tion, haemodialysis, peritoneal dialysis, and palliative
care.Secondly,itenabledthedescriptionofinfluencing
factors on decision making for this population and the
developmentofanalyticalthemesthatcouldbeapplied
across therapies and diverse treatment settings.
Selection criteria and literature search
We included qualitative studies that used interviews,
focus groups, or observations to explore patient and
carer preferences for kidney dialysis modality, trans-
plantation, or palliative care. A patient was defined as
an adult with chronic kidney disease or end stage kid-
ney disease.
16 A carer was defined as someone related
to or unrelated to, in a paid or unpaid role of support-
ing, someone receiving any form of treatment for
chronic kidney disease (excluding health profes-
sionals). We excluded qualitative studies of “withdra-
wal from dialysis” or studies that focused solely on
quality of life with dialysis or transplant. Non-English
articles were excluded to prevent cultural and linguis-
ticbiasintranslations.Weexcludedstudiesiftheyused
structured questionnaires as the sole method for data
collection, or reported only quantitative data. Studies
that did not elicit data from patients or carers them-
selves were also excluded.
We combined MeSH terms and text words for renal
replacement therapy, peritoneal dialysis, haemodialy-
sis, kidney transplant, palliative care, and chronic kid-
ney disease with terms relating to patients and
caregivers and then combined them with MeSH terms
and text words for preferences (choice, decision mak-
ing,involvement,options)andtextwordsforqualitative
methods.Usingadetailedsearchstrategy(seewebextra
appendix1)wecarriedoutsearchesinMedline(1950to
October week 1 2008), PsycINFO (1806 to October
week 1 2008), CINAHL (1982 to October week 1
2008), Embase (1980 to 2008), social work abstracts
(1977 to October week 4), social science journals
(1994 to October 2008), and EconLit (1960 to 2008).
All titles in past issues of the Nephrology Nursing Journal,
QualitativeHealth Research,a n dQualitative Research upto
October 2008 were hand searched. We also searched
electronic theses, reference lists of relevant studies,
and reviews. The abstracts and studies were screened
then discarded if they did not fit the selection criteria.
Studiesthatseemedtoincluderelevantdataorinforma-
tion were retrieved and their full text versions analysed
and examined for study eligibility.
Comprehensiveness of reporting
Two researchers (RLM and AT) independently
assessedthereportingofselectedstudiesusingthecon-
solidated criteria for reporting qualitative research
(COREQ)framework,withdisagreementsresolvedby
discussion.
17 The domains of this checklist (research
team and reflexivity, study design, and data analysis
and reporting) provide a transparency of research
methodsthatallowreaderstoassessthetrustworthiness
and transferability of the findings of the primary study
totheirsetting.
18Studieswerenotexcludedorweighted
on the basis of the quality of reporting assessment.
Synthesis of findings
Quotations from participants and text under the
heading “results” or “findings” from each study
were entered verbatim into Nvivo 8 software
(QSRInternational,Melbourne,Australia)forstoring,
coding, and searching qualitative data. Thematic
synthesis involved three phases: line by line coding
of the findings of the primary studies, development of
descriptive themes, and development of analytical
themes.
18 Each study was read several times to ensure
that all the texts relating to patient and carer perspec-
tiveswereintegrated.Theconceptswereexaminedfor
similarities and differences and then grouped into a
model structure of themes.
19
RESULTS
The search yielded 593 citations. Of these, 538 were
ineligible after review of the title and abstract (fig 1).
Of the remaining55 studies,37 wereexcluded because
they did not include a patient or carer assessment of
decision making (n=7), contained quantitative
assessment only (n=7), were not primary research
(n=3), featured a quality of life focus—that is, not treat-
ment decision making (n=16), were centred around
Included in  systematic review 18 studies (462 participants)
Digital theses
(59 citations)
PsycINFO
(16 citations)
CINAHL
(219 citations)
Embase
(46 citations)
Medline
(253 citations)
593 citations Excluded on basis of title and abstract review (n=538):
  Intervention or prognosis study (n=14)
  Not adult kidney dialysis, transplant, or palliative care for end stage kidney
    disease (n=350)
  No patient or carer perspective (that is, staff perspective) (n=25)
  Quantitative assessment (no qualitative data collection or analysis) (n=65)
  Non-primary research (review, editorial) (n=36)
  Duplicate articles (n=48)
55 citations Excluded after full text analysis (n=37):
  Quality of life focus—not treatment decision making (n=16)
  “Withdrawal from dialysis” or advance directives study (n=3)
  No patient or carer perspective (that is, staff perspective) (n=7)
  Quantitative assessment (no qualitative data collection or analysis) (n=7)
  Non-primary research (review, editorial) (n=3)
  Duplicate articles (n=1)
Fig 1 | Results of search strategy and identification of publications included in review
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ment (n=3), or were repeat publications from the same
study (n=1). Eighteen studies including three unpub-
lished theses were included in the review (table 1).
20-37
These studies used focus groups or in-depth semistruc-
tured interviews from 375 patients with chronic kidney
disease who were treated by kidney transplant, perito-
neal dialysis, haemodialysis, or palliative care. Eighty
seveninformalcarersorfamilymembersofthepatients
were also included. The studies were carried out in the
United States, Canada, Denmark, Australia, Hong
Kong, and Taiwan.
Comprehensiveness of reporting of included studies
The completeness of reporting was variable across the
studies, with between 14 and 28 of the 32 items from
the consolidated criteria for reporting qualitative
research framework clearly documented (table 2).
17
All 18 studies specified the sample size and character-
istics of the participants. Seventeen included quota-
tions from respondents in their results, and seven
reported on the use of software to store, code, and
search data. Only three reported on previous relation-
shipswithparticipantsandnoneofthestudiesreported
returning transcripts to respondents.
Table 1 |Characteristics of included studies
Study Country Perspective Treatment
Total No of
participants*
Response
rate (%)
Data
collection Methodology† Analysis†
Principal experiences
explored
Ashby 2005
21 Australia Patients,
spouses
Palliative 12 30 Interviews Grounded theory Constant
comparative analysis
End of life decision making,
effect on family,
communication with staff
Bass 1999
20 US Patients, staff Haemodialysis, peritoneal
dialysis
13 Not stated Focusgroups Not stated Content analysis Freedom/control, quality of
life
Breckenridge
1997
22
US Patients,
spouses
In-centre haemodialysis,
satellite or limited care
haemodialysis,
continuous ambulatory
peritoneal dialysis
24 Not stated Interviews Grounded theory Constant
comparative analysis
Choice of treatment
modality, decision making
Chen 2007
35 Taiwan Patients Haemodialysis, peritoneal
dialysis
30 94 Interviews Grounded theory Constant
comparative analysis
Dialysis decision making,
adaptation
Courts 2000
23 US Patients,
carers
Home haemodialysis 14 Not stated Survey,
interviews
Not stated Not stated Reasons for choosing home
haemodialysis, carers’
experiences
Feild 1996
36 US Patients Transplanthaemodialysis,
peritoneal dialysis
16 62 Interviews Grounded theory Constant
comparative analysis
Treatment decision making
Fetherston-
haugh 2007
34
Australia Patients Chronic kidney disease 21 72 Interviews Not stated Thematic analysis Dialysis decision making
Harwood
2005
24
Canada Patients Haemodialysis 11 92 Interviews Not stated Content analysis Stressors approaching end
stage kidney disease
Kelly-Powell
1997
25
US Patients Haemodialysis, peritoneal
dialysis
9 Not stated Interviews Grounded theory Constant
comparative analysis
Treatment decisions,
choices, carers’ preferences
Landrenau
2006
27
US Patients Transplanthaemodialysis,
peritoneal dialysis
6 Not stated Interviews Phenomenology Phenomenological
analysis
Choice, knowledge,
information received
Landrenau
2007
26
US Patients Haemodialysis 12 Not stated Interviews Phenomenology Phenomenological
analysis
Knowledge, perceptions of
choice
Lee 2008
37 Denmark Patients Haemodialysis, peritoneal
dialysis, chronic kidney
disease
45 Not stated Focusgroups Not stated Not stated Patient involvement in
modalitychoice,advantages
and disadvantages of
modalities
Leung 2007
32 Hong Kong Donors,
recipients
Transplant 12 Not stated Interviews Exploratory Content analysis Decision making for
transplantation, impact of
dialysis
Lin 2005
28 Taiwan Patients Haemodialysis 12 Not stated Interviews Phenomenology Phenomenological
analysis
Experience with
haemodialysis, information
seeking, decision making
Trisolini 2004
29 US Patients,
family, staff
Chronic kidney disease,
haemodialysis
140 Not stated Focus,
Interviews
Not stated Thematic analysis Knowledge about options,
communication, role of
patient in treatment
decisions
Waterman
2006
33
US Donors,
recipients
Transplant 33 Not stated Focusgroups Not stated Content analysis Decision making for
transplantation from living
donors
Whittaker
1996
30
US Patients Continuous ambulatory
peritoneal dialysis,
haemodialysis
20 95 Interviews Grounded theory Constant
comparative analysis
Values, lifestyle, autonomy,
decision making
Wuerth 2002
31 US Patients Peritoneal dialysis,
haemodialysis
40 Not stated Interviews Not stated Thematic analysis Factors influencing choice of
modality
*Only patients or carers.
†As reported by authors.
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Four major themes were identified as being central to
treatment choices: confronting mortality (choosing life
ordeath,beingaburden,livinginlimbo),lackofchoice
(medical decisions, lack of information, constraints on
resources), gaining knowledge of options (peer influ-
ence,timingofinformation),andweighingalternatives
(maintaining lifestyle, family influences, maintaining
the status quo; fig 2). Table 3 lists the studies that
reported or discussed each theme. Table 4 provides a
selection of quotes from participants and explanations
offered by the authors to illustrate each theme.
Confronting mortality
The theme confronting mortality encompassed the
thoughts, feelings, and attitudes of patients and their
families confronting chronic kidney disease as a life
threatening illness. Choosing life or death related to
patients contemplating palliative care (or rejecting it)
andwhateffectthiswouldhaveontheirfamily.Beinga
burden emphasised the feelings patients had about
undertaking rigorous renal replacement therapy and
the effort others would have to make to support this
decision.Livingin limbo described the inertiapatients
and carers felt through not knowing when end stage
kidney failure would occur, and the resulting inability
to make clear decisions.
Choosing life or death—Most respondents considered
the possibility of their own death as they anticipated
thefutureandmadepersonalchoices.Somedescribed
being startled by the conscious realisation that they
could die from their disease. Patients from five studies
displayed a preference for palliative management
rather than intensive hospital treatments. These
patients (mostly elderly) accepted the terminal nature
of their disease and were not prepared to make the
necessary changes to lifestyle associated with dialysis.
Others thought it was not yet their time to die and
thereforedidnotseriouslyconsiderrefusingtreatment.
Patientsfromtwostudiesdescribedchronickidneydis-
easeasanopportunitytore-evaluatelife;establishnew
priorities,suchasrelationshipswithfamilyandfriends;
and reconsider life as a spiritual journey.
Being a burden—The desire not to be a burden on
family members was a prominent reason for patients
choosing palliative management. Older patients in
eight studies talked about the disruption dialysis
would have to the lives of their spouse or children.
Living in limbo—Patients receiving dialysis or pallia-
tivecarereferredtotheprognosticuncertaintyoftrans-
plantation or death. Patients talked about not knowing
how long they would have to continue with dialysis
before a kidney was available and this influenced
their decision on whether to go on the waiting list.
Patients receiving palliative care were unsure how
long they would live, and this made them doubt the
medicalinformationtheywerereceivingandtorecon-
siderwhethertheyweremakingtherightchoice.They
thought that the uncertainty of their prognosis inhib-
ited their ability to make adjustments to their lifestyle,
such as selling their assets and moving into assisted
care accommodation.
Lack of choice
The theme lack of choice described the perceived lack
of individual choice in decision making about treat-
ment. Medical decisions referred to clinicians exclud-
ing a particular treatment option owing to either
medical contraindications or physician preference.
Lack of information related to patients not knowing
about all available treatment options, thereby limiting
their choices. Constraints on resources described the
patients’ and carers’ lack of treatment choice owing
to the limitations of their treating renal centre.
Table 2 |Comprehensiveness of reporting assessment (consolidated criteria for reporting
qualitative research checklist)
17
Reporting criteria
No (%)
(n=18)
References of studies
reporting each criterion
Characteristics of research team:
Interviewer or facilitator identified 16 (88) 20-24, 26-28, 30-37
Credentials 12 (67) 20, 22, 24, 26-28, 30, 32-36
Occupation 13 (72) 22-24, 26-28, 30, 32-37
Sex 12 (67) 21, 23, 26, 27, 29, 30-32, 34-37
Experience and training 11 (61) 21, 22, 24, 26, 28, 31-36
Relationship with participants:
Relationship established before study started 3 (17) 24, 34, 36
Participant knowledge of interviewer 10 (56) 21-24, 26, 27, 32, 34, 36, 37
Methodological theory identified 12 (67) 21-24, 26-28, 30-32, 35, 36
Participant selection:
Sampling method (for example, snowball,
purposive)
16 (88) 20-32, 34-36
Method of approach 16 (88) 20-29, 31, 33-37
Sample size 18 (100) 20-37
Number or reasons for non-participation 11 (61) 21-25, 30-32, 34-36
Setting:
Setting of data collection 13 (72) 20-24, 26, 29-32, 35-37
Presence of non-participants 3 (17) 21, 22, 36
Description of sample 18 (100) 20-37
Data collection:
Interview guide 15 (83) 20, 22-24, 26-36
Repeat interviews 4 (22) 21, 25, 34, 36
Audio or visual recording 16 (88) 20, 21, 23, 25-37
Field notes 4 (22) 23, 25, 26, 34
Duration 13 (72) 20-22, 25, 26, 28-33, 35, 36
Data (or theoretical) saturation 9 (50) 21, 22, 24-26, 28, 30, 31, 36
Transcripts returned to participants 0 (0) —
Data analysis:
Number of data coders 12 (67) 20, 24, 26-28, 30-35, 37
Description of coding tree 11 (61) 20, 22, 24, 26, 28-32, 35, 36
Derivation of themes 16 (88) 20, 22, 24-37
Protocol for data preparation and transcription 7 (39) 20, 22, 23, 26, 29, 31, 35
Use of software 7 (39) 22, 27, 29, 34-37
Participants’ feedback or member checking 5 (28) 24, 25, 27, 34, 36
Reporting:
Participant quotations provided 17 (94) 20-30, 32-37
Data and findings consistent 14 (78) 21, 22, 24, 26-28, 30-37
Clarity of major themes 18 (100) 20-33, 35-37
Clarity of minor themes 11 (61) 20-22, 25, 26, 28, 30-32, 35, 36
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talked of decisions about treatment options being
madeforthembecauseofeitheraphysiologicalcontra-
indicationsuchastheinabilitytocreatevascularaccess,
or physician preference. Patients from nine of the 18
studiesobtainedanunderstandingoftreatmentoptions
fromtheirnephrologistorrenalnurse,andthewaythis
informationwasframedinfluencedtheirdecisionmak-
ing.Forexample,onepatientdismissedtransplantation
afterhearingitwas“asixhouroperationthatwasarisk
between life anddeath.”
26 Patients andcarersfrom five
studieshighlightedthedifficultyinchangingtreatment,
particularlyiftheystartedhospitalbasedhaemodialysis
but preferred another modality. Some patients will-
ingly accepted a physician led choice of modality, par-
ticularlywhentherationalewasexplainedtothem,and
others perceived they had a choice in renal replace-
menttherapyevenwhentheyhadlimitedinvolvement
in choosing their treatment.
Lack of information—Eleven of 18 studies reported
that patients or their carers did not have the informa-
tion they wanted on treatment options, regardless of
whether transplantation, dialysis, or palliative care
was preferred. Family members of patients were espe-
cially concerned about their lack of knowledge of the
different treatments available and the practicalities in
managing each treatment.
Constraints on resources—Ten studies reported that
dialysisortransplantresources(suchasspaceatasatel-
lite facility or availability of kidneys) formed the basis
of treatment decisions. Limited access to centre based
dialysis was a consistent reason for choosing haemo-
dialysis at home or peritoneal dialysis. Patients from
three US studies mentioned the importance of having
health insurance that paid for dialysis. Patients were
generally reluctant to initiate discussions with friends
or relatives about living kidney donation but verba-
lised their desire for a transplant and a place on the
deceased donor waiting list. One study reported
patients’andcarers’preferencesforobtainingakidney
transplant commercially rather than waiting for an
organ from a deceased donor.
Gaining knowledge of options
Thethemegainingknowledgeofoptionsdescribedthe
waysinwhichthepatientsandtheircarerslearntabout
treatment options, and the factors influencing their
decision making. Peer influence referred to the impact
of other patients’ experiences on treatment decision
making.Timingofinformationrelatedtotheprovision
of information on treatment options along the trajec-
tory of chronic kidney disease, with reference to other
events such as hospital admissions for acute illness or
creation of vascular access.
Peerinfluence—Patients weregreatly influencedby the
experiences of other patients. They imagined them-
selves in a similar position (for example, looking really
well after transplantation or managing a Tenckhoff
catheter) and described being inspired to carry out dia-
lysis themselves. Similarly, some patients dismissed a
particular therapy after seeing complications in other
patients, such as refusing haemodialysis after seeing a
swollenanddisfiguredarmfollowingafistulaoperation.
Timing of information—Ten studies reported the
importance of the timing of information on treatment
options. Patients recounted being too unwell to take in
the information presented or too rushed into making a
decision without having time to discuss the options
with their families. Information about kidney trans-
plantation was commonly introduced to patients after
dialysis had been established. For some patients infor-
mationabouttreatmentoptionscameafterundergoing
surgery for vascular access.
Weighing alternatives
When treatment options were presented, patients’
decisions were influenced by a desire to “maintain
their pre-existing lifestyle” and were shaped by opi-
nions offamily andfriends. Oncea treatmentpathway
Table 3 |Themes identified in each study
Themes
Study reference
20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37
Confronting mortality:
Choosing life or death — Yes Yes Yes Yes Yes ——Yes Yes ———Yes Yes — Yes —
Being a burden — Yes ———Yes ——Yes ———Yes Yes Yes Yes Yes —
Living in limbo — Yes ———Yes — Yes ————Yes ———Yes —
Lack of choice:
Medical decisions Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes — Yes Yes Yes Yes
Lack of information Yes Yes Yes — Yes ——Yes — Yes Yes Yes ——Yes — Yes Yes
Constraints on resources ——Yes Yes Yes — Yes Yes Yes Yes ——Yes Yes Yes ———
Gaining knowledge of options:
Peer influence ——Yes Yes Yes — Yes — Yes ———Yes Yes Yes Yes Yes Yes
Timing of information ——Yes Yes Yes — Yes Yes — Yes — Yes ——Yes — Yes Yes
Weighing alternatives:
Maintaining lifestyle ——Yes ——Yes ————Yes Yes ——Yes Yes Yes Yes
Family influences — Yes Yes Yes Yes Yes ——Yes Yes Yes Yes Yes Yes Yes Yes Yes —
Maintaining the status quo ——Yes ———————Yes ——Yes Yes ——Yes
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status quo and switch treatments.
Maintaininglifestyle—Themedicaloutcomesoftreat-
ment were considered less important than the effect of
thetreatmentonthepatient’slifestyle—thatis,patients
were less concerned about their longevity than they
were about their quality of life. Treatment choices
were based on minimising disruption to usual activ-
ities, upholding responsibilities, and maintaining per-
sonal interests.Examples of this included the ability to
continue working, maintain a social life, or care for
grandchildren (see table 4).
Family influences—Fourteen studies reported that the
preferences of the family and carer had a strong influ-
ence on patients’ choice of treatment. Family influ-
ences ranged from support to drive patients to their
place of dialysis, offers of living kidney donation, or
censoringofinformationontreatmentoptionsnotcon-
gruent with the family’s wishes.
Maintaining the status quo—Patients expressed reluc-
tancetochangetreatmentonceitwasestablished,indi-
cating a preference for the status quo. This included
switching from haemodialysis to peritoneal dialysis
and from dialysis to transplantation. This was particu-
larly evident when a patient had a functioning fistula.
Patients verbalised a perceived risk in changing treat-
ments and were fearful of additional surgery or poten-
tialcomplicationsresultingininfectionordeath.Many
described how they learnt to accept and adjust to the
treatment they were on regardless of their initial
preference.
Specific preferences for dialysis modality
When a choice of treatments was offered to patients
thiswasusuallybetweenhaemodialysisandperitoneal
dialysis. Fifteen studies described specific preferences
for dialysis modality according to the established
themes (table 5).
DISCUSSION
The four themes that emerged from this synthesis of
primary studies (confronting mortality, lack of choice,
gaininginformationaboutoptions,andweighingalter-
natives) were relevant to decision making across all
treatments for chronic kidney disease. Many patients
perceivedtheyhadlimitedchoicesintreatment.When
choice was offered, preferences for peritoneal dialysis
were based around privacy, freedom, and flexibility,
whereaspreferencesforhaemodialysiswereattributed
to a planned schedule, regular social contact, and pre-
vious knowledge of the therapy. Patients with a strong
preference for transplantation wanted to resume a
“normal life,” and those who opted for palliative man-
agementwerenotpreparedtoundertaketherigoursof
dialysisbutwantedsupportiveendoflifecare.Overall,
patientswerelessconcernedabouttheirlongevitywith
a specific treatment and more concerned about its
impact on their quality of life.
Factors influencing decision making
This synthesis highlighted three major factors that
influenced decision making that were over and above
the findings from the primary studies alone. The first
wastheimpactofpeersondecisionmakingbypatients
and carers, the second was the problematic timing of
information presented, and the third was the desire by
patients to maintain the status quo.
Peer influence
Peer influence was a powerful and persuasive method
for patients to gain knowledge of their treatment
options. Meeting other patients and listening to their
experienceshelpedpatientsandtheircarerstoconcep-
tualise the reality of dialysis and transplantation. Peers
mayhavebeenmoreinfluentialthancliniciansindeci-
sion making.
Timing of information
Participants often reported being too sick to make
sense of the information they were given on treatment
options:“The doctormight have mentionedit [contin-
uousambulatoryperitonealdialysis]butIwassosickat
the time I didn’t catch on to it.”
22 Patients and families
alsoidentifiedneedingtimetoabsorbinformationand
to adjust to the approaching treatment regardless of
whethertheywerecontemplatingahomehaemodialy-
sis modality or palliative care.
Research on nephrologist-patient communication
suggests that nephrologists provide information on
treatment options over an extended period of time
but increase the amount of detail about specific treat-
ments when the patient requires renal replacement
therapy.
38 Although this sounds reasonable it is likely
that this approach will reduce the time available to
patientstomakedecisionsandmeansthatinformation
provision will coincide with the patient becoming
symptomaticorcognitivelyimpaired.Fromapatient’s
perspective this practice of increasing discussions
abouttreatmentoptionswhenendstagekidneydisease
is approached is inadequate for decision making.
3940
Guidelines for chronic kidney disease from the UK
and kidney disease quality outcomes initiative recom-
mend counselling for treatment options six months
before the onset of established renal failure.
3940 These
same guidelines, however, also recommend that a
Factors influencing decision making about treatment for chronic kidney disease
Maintaining status quo Family influences Being a burden Living in limbo
Lack of information
Maintaining lifestyle Choosing life or death
Timing of information Constraints on resources
Peer influence Medical decisions
Confronting mortality Weighing alternatives
Lack of choice Gaining knowledge of options
Fig 2 | Components of each theme identified as influencing treatment decisions
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Themes Quotations from participants in primary study Interpretations of findings offered by authors
Confronting mortality
Choosing life or
death
Iseeitasanaturalcourse.Yousee,Ihavenoloyalty.Imeanmychildrenaregrownupnowandthey
have got their husbands and their children. And there is nothing to make me think oh I had better
stay around
21
Patients over 77 years of age tended to see dying as a natural course that they
would prefer to take, rather than to burden their children with issues relating to
dialysis
21
I got too much going . . . I’ve been married 12 years and I’ve got two little girls. There was no
question
36
Love and responsibility for family members gave many patients meaning and
purpose in continued survival
36
Once I went through the fact that I had no choice, it was either that or die—it was either haemo,
peritoneal or die. Those were my three choices. And it was like, “Oh”
36
Acceptance of kidney failure permitted patients to face reality and move on
36
Being a burden No like I said when we came home we sat down and had a talk, just Alice and meself there and we
thought about it, I thought about it and ah, I didn’t want to go on that dialysis to be a burden to
Alice. You know three days a week and five hours or whatever. And I say I didn’tw a n tt op u tt h a to n
her because she had enough putting up with me as it was
21
The desire not to be a burden was a prominent contributory reason for patients
choosing not to start dialysis. Patients expressed concern about the disruption
that dialysis would cause to their family life
21
Living in limbo They can’t tell you, you know, how long you have to go. You see this is quite true, they don’t know.
With all the modern stuff and all that, they still don’t know
21
Prognostic unpredictability affected those who were receiving palliative care.
Each expressed desire for their deaths to come quickly and be pain free
21
Lack of choice
Medical decisions
I askedhim[doctor] aboutdid heever sign me upfor a transplantandhesaid he couldn’t cause my
kidneys has hardened and there was no use to try to go in with no transplant
26
Physiologically dictated decision—ap a t i e n t ’s physiological limitations dictated
modality choice
22 26
Well it looks like I’m going to have to have the stomach one because the fistulas are just not
working. I’ve had three
34
Some patients willingly accepted a physician led decision on modality
30
Since he [nephrologist] owned four haemodialysis units, his suggestion was that I go on haemo
30 Patients perceived they had a choice in renal replacement therapy even when
they had limited involvement in choosing their treatment
26
The only thing the doctor said was that I was going to be on dialysis. I didn’t know it was like this. I
didn’t have a choice. He didn’t say you have choices of dialysis, which one would you like? I was
told the one. I was going to be on this machine. That’si t
22
Some patients thought there was no patient choice in decision making on
modality
22
Lackofinformation
When I went on dialysis I was automatically put on haemodialysis. I was not even told about CAPD
[continuous ambulatory peritoneal dialysis]
22
Thelackofinformationinpatienteducationsessionsaffectedpatient’squalityof
life
20; patients who preferred a more autonomous or collaborative decision
making process wanted more information
36
They don’t tell you everything you need to know . . .
20
I just took the pills (prednisolone) and I was told a few things, but not, I don’t feel nearly enough
things. I was not aware of the fact that your vision could be affected
36
Constraints on
resources
I tried to get in to GS [another facility] but they were booked up and there were no openings, but
there was an opening here
22
Access rationing decision: the patients’ stated choice of modality was based on
factors such as availability at a dialysis centre
22
I’m going to get a kidney transplant from a relative
26 Usually dialysis was presented as an option first, then transplant once dialysis
was established
27
Theday Ifoundout thatmykidneys hadfailed,uh, thedoctorstheretoldmethatI wouldhavetogo
on dialysis and uh, they asked me would you want a kidney transplant. And I said, yes I would,
cause I didn’t want to do this all my life. So, I told them put me on the list
26
Physicians recommended home haemodialysis when there was no close in-
centre haemodialysis. Patients also chose home haemodialysis based on long
distance from home to a centre. One patient stated that he did not want to ride
the bus to another town and spend so much time travelling
23
Gaining knowledge of options
Peer influence
Another woman was at the unit where I was on dialysis, and she was on CAPD [continuous
ambulatory peritoneal dialysis]. She told me about it and I knew this was something I wanted to
do
22
Patients were influenced greatly by other patients
22; other patients were
especially important as role models
36 I saw people on home HD [haemodialysis] and they looked better
24
Just by listening to [other patients] and talking to them and they tell me how things go and all that,
that is really helpful
36
Timing of
information
The doctor mighthave mentioned it [continuous ambulatory peritoneal dialysis]butI was so sick at
the time I didn’t catch on to it. My response was that if had been told about something like that, I
would have wanted to go with it
22
Patients identified needing time to absorb information and adjust to the
approaching dialysis
24; patients and carers stated that it took time to find their
own way ofhandling a chronicdisease
37; decisionsare often madeunder highly
stressful, and physically demanding situations when patients are sick. Often
made rapidly, without enough time to consider options properly
27; seven of 12
patients receiving haemodialysis stated that they were too sick to make a
decision and that the decision had been made for them during hospital stay
31
I received the book (Kidney Foundation of Canada, 1999), which explained things quite well. But [I]
didn’t absorb the information. [It was] difficult to grasp
24
Weighing alternatives
Family influences
My husband disagreed with the treatment. He was too busy to take me to the hospital
28 Familiesexertedpressureonthepatientstochoosethemodalitythatbestsuited
the family members’ desires
30
Idiscussedthedecisionwithmyhusband,andhesaidtheCAPD[continuousambulatoryperitoneal
dialysis] was better for me because I could still do housework at home
35
Familymemberswereespeciallyinterestedinwaystoexpandtheirrolestobetter
support patients. They were also more likely than patients to have internet
access
29
My husband has to be able to accept it [home haemodialysis]. If he can’t, then we won’td oi t
37 Relatives felt the decision to dialyse affected their lives too
37
Maintaining
lifestyle
One of the first reactions I had was “How am I going to keep my job?” I go to work and then have to
leave probably by noon three days a week, I’m only going to put in half a day of work. This is not
going to work for me and I’m sure its not going to work for my employer
30 Medical effectiveness was less important than the effect of treatment on the
course of patients’ lives
25
I have a son and I would have to go to the hospital every other day for haemo. It was real hard for
me. With peritoneal, I could be in my own surroundings at home
30
Maintaining the
status quo
They had to put me right away on dialysis. They explained to me about the other one [continuous
ambulatory peritoneal dialysis] but I liked this one better. I prefer this one [in-centre
haemodialysis]
22
Thismanfeltlikeacutehaemodialysishadsavedhislifeandthereforewantedto
stay with it. Switching may have been a risk
30;s o m ep a t i e n t ss t a yw i t h
haemodialysisbecausetheyalreadyhaveafistula(vascularaccess)createdand
don’t want to risk further surgery
30; patients felt a sense of security obtained
from familiarity
37
I felt like the machine saved my life and since that was already doing the job, I didn’t feel like
crossing over [switching modalities]. I think in the beginning, the one you start with has a lot to do
with it
30
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 7 of 10native arteriovenous access be created six months
before end stage renal disease.
3940 There are several
potential consequences of having a fistula created
before a full discussion of treatment options. Firstly,
patients risk having surgery for a treatment they do
not wish to pursue. Secondly, our analysis suggests
that the creation of vascular access may mean that a
patient believes a treatment choice has already been
made for them.
Maintaining the status quo
When weighing up alternatives for treatment, patients
are reluctant to change treatments despite the potential
advantages—thatis,doingnothingormaintainingacur-
rent or previous decision is preferable to change.
4142 It
seemed that maintaining the status quo, which was
usually continuing with hospital based haemodialysis,
was preferable for many patients rather than risking a
change to a different treatment. Once vascular access
was created, patients were especially reluctant to
considerothertreatments,eventoacceptakidneytrans-
plant.Althoughcreationofvascularaccessmaybecon-
sidered a good back-up regardless of treatment
preference, to a patient it can be perceived that a treat-
ment choice has been made thereby limiting their con-
siderationandchoiceofperitonealdialysis,pre-emptive
transplant,orpalliativecare:“Ohwellthey,thedoctorI
wasseeingatthetimeovertheresortofknewIwasabit
iffy(abouthaemodialysis)ah,butIthinkwhenIagreed
tohavethefistulaputinmyarmshemighthavethought
I was saying yeh I’dd oi t . ”
34
Strengths and limitations of the review
This study incorporated the experiences of decision
makingin alltreatmentoptionsforchronickidneydis-
ease,includingpalliativecare,transplantation,anddia-
lysis, and usedrigorousmethodsforsystematic review
thatincludedacomprehensivesearchofpublishedand
unpublishedstudiesusingpredeterminedcriteria.This
review also included the findings from relevant
Table 5 |Patients’ and carers’ preferences for dialysis modality
Modality and reasons for choosing or not choosing modality Participants’ quotes
Peritoneal dialysis
Reasons for choosing modality:
Self capability v depending on care from strangers I like taking responsibility for my own care . . .
20
Managing illness in privacy of own home With haemodialysis there’s no partition, no privacy. I couldn’t even meditate
36
More freedom or flexibility “Mainly because it [peritoneal dialysis] gives me a little bit more freedom. Being able to do it at home I wouldn’th a v et o
come to the hospital
22
Less time in hospital I am a pharmacist . . . worked eight hours in the hospital. I did not want to spend the rest of my time in hospital again
35
Ability to travel It would allow me if I wanted to take a trip, to go somewhere and basically do it myself, instead of having to try to find a
facility that could accommodate me
22
Ability to continue part time work I need flexibility to go where the meetings are and to get up and move around. CAPD [continuous ambulatory peritoneal
dialysis] seemed like it would allow me to function in those capacities
30
Ability to continue care giving for children I have a son and I would have to go to the hospital every other day for haemo. It was real hard for me. With peritoneal, I
could be in my own surroundings at home
30
Reasons for not choosing modality:
Concerns about having Tenckhoff catheter Itmakesmefeel uncomfortable tosee thatthing thatcomes outofyourstomach.Itgivesmea funny feelinglike someone
scratching a chalkboard
30
Concerns about sterility in home and getting an infection Peritoneal dialysis is sterile and can’t be done at my home
26
Inability to store dialysis supplies Where we wereliving previously there wasno space [for peritoneal dialysis supplies]. We couldn’t getone iota of anything
else in that place
36
Haemodialysis
Reasons for choosing modality:
Liked others caring for them I know we couldn’t do CAPD [continuous ambulatory peritoneal dialysis]. No, I sooner trust the girls, because they’re
supposed to know about it
30
Preferred a planned schedule Since I usually control the scheduling of my job, the time to spend in the hospital is OK for me
35
Free days with no dialysis [Haemodialysis] would be less disruptive of our life. Two, three hours a day, every other day, and then you can go on with
your life in between times
25
Perception of haemodialysis as a “better” therapy I suppose the blood one is probably the proper one, I don’tk n o w
34
Previous knowledge of haemodialysis from family member I decided to take it with the machine because I already knew what it was like
30
Could go swimming You can’t go swimming with that damn thing [peritoneal dialysis catheter]. This way, I don’t have no openings, I can go
swimming anytime I want, I don’t have to worry about dirty water or whatever getting into it
30
Convenience The haemodialysis centre’s right close to my home. It’s real convenient
36
Reasons for not choosing modality:
Needle phobia There’s a big machine and you see blood and for me its scary. With haemo there’s more needles involved, its more
dangerous
30
Looking like a “patient” My mother said that having a fistula on the arm would show I was a patient. However, with an abdominal catheter on the
belly people would not know . . .
35
Fear of cross infection Haemo is pretty dangerous because you don’t know whose blood is where. What assurance would I have that somebody
else’s blood was not in the machine somewhere
30
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reporting was assessed according to a published
framework,
17whichallowedreaderstojudgeforthem-
selvesthequalityofincludedstudiesandgeneralisabil-
ity to their own context. We combined eligible studies
of experiences in treatment decision making from
patients’ and carers’ perspectives in a deliberate
attempt to achieve the higher level analytical abstrac-
tion that is aimed for in thematic synthesis. Despite
different contexts, our themes, developed from the
experiences of 462 participants, indicated consider-
able overlap from each of the primary studies.
We used previously applied methods for systematic
reviews of patients’ experiences and perspectives to
synthesise findings, emphasising transparency in the
development of descriptive and analytical
themes.
184344 Comprehensive details were provided
about the primary studies including research team
characteristics, participants, settings, and methods as
reported by the authors of each study. We found the
primary studies that were more comprehensive in
their reporting contributed most to the final analytical
themes. The review was limited to the experiences of
participantsintheincludedprimarystudiesandunder-
represented people from non-English speaking back-
grounds and those seeking palliative care. We were
unable to ascertain the level of literacy of most study
participants and therefore cannot make any conclu-
sions regarding experiences in decision making about
treatment within the context of low literacy. The find-
ings may not be generalisable to patients and carers
elsewhere; however, the analytical themes offer a
higherlevelofconceptualthinkingaboutdecisionmak-
ing that may be applicable across different contexts.
Implications of the review
Several strategies to improve patient care could be
implemented immediately as a result of this synthesis.
Firstly, the formal incorporation of peers (other
patients) with chronic kidney disease as mentors or
educators into the “orientation” of new patients to the
renal unit may be beneficial. Secondly, the rewording
ofclinicalpracticeguidelinesforoptimaltimingofedu-
cation about treatment options should be updated to
recommend giving information at stage 4 disease
when the estimated glomerular filtration rate first
drops below 30 ml/min/1.73 m
2, well before the crea-
tion of access for dialysis. Thirdly, formal care path-
ways for pre-emptive transplantation and home
dialysis (both haemodialysis and peritoneal dialysis)
as well as for palliative management for patients not
wishing to dialyse should be developed, such that
patients can start renal replacement therapy outside
an acute haemodialysis centre, to facilitate provision
of treatments more aligned with their preferences.
As a result of the paucity of data in renal palliative
care, further research, such as that being done in the
UK,
45 is required to inform clinicians about the needs
of the growing cohort of elderly patients who choose
nottohavedialysis.Qualitativeresearchwouldprovide
valuable insight into the effectiveness of formal pallia-
tive care pathways from the perspective of patients,
carers, and clinicians. A randomised controlled trial
comparingmodesofeducationcouldprovidedefinitive
answers about the effects of peer education for new
patients. In addition, research that specifically deals
with the views of culturally and linguistically diverse
people regarding decision making about treatment is
needed. The role of qualitative research in evidence
based medicine has become clearer in recent years.
4647
Synthesisofqualitativestudiescan provideevidenceto
research questions concerning patients’ or practi-
tioners’ experiences (what works, for whom, and
under what circumstances), opportunities for and bar-
riers to improvement (including issues of access or
acceptability), and an explanation of the associations
between interventions and outcomes.
47
Conclusions
This thematic synthesis of qualitative studies on deci-
sion making about treatment for chronic kidney dis-
ease shows that the requirements of many patients
and their carers are not being met. Factors influencing
treatment decisions included the experiences of other
patients (peer influence); the problematic timing of
informationabouttreatmentoptionsand synchronous
creation of vascular access, which appeared to prede-
termine haemodialysis and inhibit choice of other
treatments(includingpalliativecare);andapreference
to maintain the status quo may explain why patients
often continue with their initial therapy.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
One third of patients with chronic kidney disease receive information about treatment
options after starting dialysis, contrary to current clinical guidelines
For patients, lifestyle considerations rank higher than medical consequences of specific
treatments in their decision making
WHAT THIS STUDY ADDS
Thematic synthesis ofqualitative studies is valuableinunderstanding patients’ perspectives
and can inform practice and policy
The problematic timing of information about treatment options and synchronous creation of
vascular access may predetermine the use of haemodialysis and limit choice of other
treatments, including palliative care
Patients have a strong preference for the status quo and are reluctant to change treatments,
which may help explain why patients often continue with their initial therapy
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 9 of 10Data sharing: A full list of participants’ quotes and explanations offered
by the authors to illustrate each of the four themes are available on
request from the corresponding author at rachaelm@health.usyd.ed.au.
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